Dezhan Healthcare Company Limited (SHE:000813)
China flag China · Delayed Price · Currency is CNY
2.800
-0.080 (-2.78%)
Nov 13, 2026, 3:04 PM CST

Dezhan Healthcare Company Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
348.45396.04465.59496.37570.74729.81
Other Revenue
0.770.770.91.720.114.67
349.22396.81466.49498.09570.86734.48
Revenue Growth
-10.34%-14.94%-6.35%-12.75%-22.28%-23.72%
Cost of Revenue
191.26185.58170.39223.13359.44261.42
Gross Profit
157.96211.23296.09274.96211.41473.06
Selling, General & Admin
279300.62293.26263.26303.62342.89
Research & Development
94.6882.2868.3751.151.4967.06
Other Operating Expenses
15.1112.859.2911.479.4612.3
Operating Expenses
377.27393.25376.76330.64364.51423.29
Operating Income
-219.31-182.03-80.67-55.69-153.149.77
Interest Expense
-22.26-2.31-0.37-0.37-0.71-0.65
Interest & Investment Income
-17.2266.36148.3286.884.82
Currency Exchange Gain (Loss)
000-1.87-3.46-0.23
Other Non Operating Income (Expenses)
-16.96-57.04-10.28-10.95-9.94-164.68
EBT Excluding Unusual Items
-258.53-224.16-24.9679.45-80.4-30.97
Impairment of Goodwill
-43.87-43.87----14.2
Gain (Loss) on Sale of Investments
-108.12-109.92-19.87---
Gain (Loss) on Sale of Assets
1.581.38-0.02-0.030.330.02
Asset Writedown
-53.25-45.77-1.56-7.23-41.98-0.31
Other Unusual Items
1.141.922.39.650.988.36
Pretax Income
-461.05-420.42-44.1181.84-121.08-37.11
Income Tax Expense
0.911.5-1.8927.632.3859.09
Earnings From Continuing Operations
-461.96-421.93-42.2254.24-153.46-96.2
Minority Interest in Earnings
74.0876.5121.8129.07106.5138.62
Net Income
-387.88-345.42-20.4183.31-46.95-57.58
Net Income to Common
-387.88-345.42-20.4183.31-46.95-57.58
Net Income Growth
------
Shares Outstanding (Basic)
2,1002,1152,1492,1812,2152,241
Shares Outstanding (Diluted)
2,1002,1152,1492,1812,2152,241
Shares Change
0.10%-1.56%-1.48%-1.52%-1.15%0.95%
EPS (Basic)
-0.18-0.16-0.010.04-0.02-0.03
EPS (Diluted)
-0.18-0.16-0.010.04-0.02-0.03
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-269.65-231.27-181.14-31.8694.16-84.51
Free Cash Flow Per Share
-0.13-0.11-0.08-0.010.04-0.04
Gross Margin
45.23%53.23%63.47%55.20%37.04%64.41%
Operating Margin
-62.80%-45.87%-17.29%-11.18%-26.82%6.78%
Profit Margin
-111.07%-87.05%-4.38%16.73%-8.22%-7.84%
Free Cash Flow Margin
-77.22%-58.28%-38.83%-6.40%16.50%-11.51%
EBITDA
-133.79-98.450.3125.7-64.27127.85
EBITDA Margin
-38.31%-24.81%0.07%5.16%-11.26%17.41%
D&A For EBITDA
85.5283.5780.9881.3988.8378.08
EBIT
-219.31-182.03-80.67-55.69-153.149.77
EBIT Margin
-62.80%-45.87%-17.29%-11.18%-26.82%6.78%
Effective Tax Rate
---33.72%--
Revenue as Reported
119.31396.81466.49498.09570.86734.48
Advertising Expenses
-44.0846.3552.54108.97148.13